Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 −/− epithelial ovarian cancers-Reference-Cited by-同舟云学术

Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 −/− epithelial ovarian cancers

Published:2006-07 Issue:10 Volume:42 Page:1475-1483
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Indraccolo Stefano,Tisato Veronica,Agata Simona,Moserle Lidia,Ferrari Silvia,Callegaro Monia,Persano Luca,Palma Maurizia Dalla,Scaini Maria Chiara,Esposito Giovanni,Fassina Ambrogio,Nicoletto Ornella,Plebani Mario,Chieco-Bianchi Luigi,Amadori Alberto,D’Andrea Emma,Montagna Marco

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer;Risch;Am J Hum Genet,2001

2. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes;Gayther;Am J Hum Genet,1999

3. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies;Antoniou;Am J Hum Genet,2003

4. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage;Yoshida;Cancer Sci,2004

5. The role of BRCA1 in the cellular response to chemotherapy;Kennedy;J Natl Cancer Inst,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair;Cancers;2023-12-06

2. Quantification of Tumor and Angiogenesis-Related Markers in Ovarian Cancer Models by a Digital Pathology Approach;Methods in Molecular Biology;2022-09-27

3. p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics);Frontiers in Pharmacology;2022-05-27

4. BBIT20 inhibits homologous DNA repair with disruption of the BRCA1–BARD1 interaction in breast and ovarian cancer;British Journal of Pharmacology;2021-06-11

5. In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach;Frontiers in Oncology;2020-08-19